A working case definition was developed, identifying affected individuals as previously healthy and under the age of 16, presenting with acute hepatitis (non-A-E) with serum aminotransaminases greater than 500 IU/L (alanine aminotransferase [ALT] or aspartate aminotransferase [AST]), since 1 October 2021. This evidence concerns the gene GPT and Acute hepatitis.